
Margaret Hamburg, M.D.
Co-president, InterAcademy Partnership
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI applauds today’s announcement that the International Negotiating Body of the World Health Organization (WHO) has reached a deal on the language of the Pandemic Accord. Pandemics continue to pose a global threat, and this proposed agreement is proof that the world can unify to reduce the most catastrophic risks.
NTI | bio has responded to the U.S. government request for information (RFI) related to the Artificial Intelligence (AI) Action Plan outlined by President Donald Trump’s January 2025 Executive Order, providing input on the highest priority actions to maintain and extend U.S. global leadership on AI.
NTI | bio hosts this competition to provide a platform for the next generation of global leaders in biosecurity to develop original concepts and share them with the wider biosecurity community.